Multi-centers clinicopathological prognosis study of inflammatory myofibroblastic tumors of urogenital system in China
Bo Chen,He Xu,Dehong Cao,Jianbing Guo,Zeyu Chen,Yin Huang,Shi Qiu,Tianhai Lin,Na Ma,Liangren Liu,Qiang Wei
DOI: https://doi.org/10.21203/rs.2.11394/v1
2019-01-01
Abstract:Purpose: We aimed at investigate a series of inflammatory myofibroblastic tumors (IMTs) of urogenital system in multi-centers in China.
Materials and methods: Within the pathologic databases at West China Hospital of Sichuan University and the Third People’s Hospital of Chengdu, we identified 33 individuals with IMTs from May 2009 to January 2019
Results: A total of 33 patients with IMTs of urogenital system were identified. The median age of all the individuals was 39.5 years (range 0-74 years). The most common presentations were hematuria (13patients), pain (12 patients), and mass (12 patients). In addition, other clinical symptoms included dysuria, urinary frequency, and fever. Fourteen individuals were diagnosed with anemia, including 10 mild anemia patients and 4 moderate anemia cases. Moreover, neutrophil was the dominant inflammatory cell type. The main positive markers of immunohistochemistry staining included SMA (22/25), MSA (8/9), CD34 (15/17), and CD68 (3/3). Surgery resection was the sole treatment for all the patients. Follow- up was available in 23 patients during a median follow-up period of 78.3 months (range 19.2-118.8 months), and either recurrence or metastasis was detected in any patients except one patients died from retroperitoneum IMTs.
Conclusion: This study confirmed that urogenital system IMTs, with potential of recurrence or metastasis, are extremely rare. In summary, although favorable prognosis was observed in IMTs of urogenital system, closely follow-up is essential and needed.